Adietika Pharma Profile
Key Indicators
- Authorised Capital ₹ 1.80 Cr
- Paid Up Capital ₹ 1.70 Cr
- Company Age 28 Year, 7 Months
- Last Filing with ROC 31 Mar 2011
- Open Charges ₹ 7.47 Cr
- Satisfied Charges ₹ 7.15 Cr
About Adietika Pharma
Adietika Pharma Private Limited (APPL) is a Private Limited Indian Non-Government Company incorporated in India on 12 June 1996 and has a history of 28 years and seven months. Its registered office is in Delhi, India.
The Corporate was formerly known as Dietika Foods (I) Pvt Ltd. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2011. It's a company limited by shares with an authorized capital of Rs 1.80 Cr and a paid-up capital of Rs 1.70 Cr.
The company currently has active open charges totaling ₹7.47 Cr. The company has closed loans amounting to ₹7.15 Cr, as per Ministry of Corporate Affairs (MCA) records.
Hardeep Singh and Sunita Sharma serve as directors at the Company.
Company Details
-
Location
Delhi, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U74899DL1996PTC079610
-
Company No.
079610
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
12 Jun 1996
-
Date of AGM
29 Sep 2011
-
Date of Balance Sheet
31 Mar 2011
-
Listing Status
Unlisted
-
ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Adietika Pharma?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Hardeep Singh
|
Additional Director | 15-Feb-2017 | Current |
|
Sunita Sharma
|
Director | 12-Jun-1996 | Current |
Financial Performance of Adietika Pharma.
Enhance accessibility to Adietika Pharma's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Adietika Pharma?
Unlock access to Adietika Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
₹7.47 Cr
₹7.15 Cr
Charges Breakdown by Lending Institutions
- Idbi Bank Limited : 7.47 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 25 Feb 2010 | Idbi Bank Limited | ₹7.47 Cr | Open |
| 19 Sep 2007 | Oriental Bank Of Commerce | ₹3.07 M | Satisfied |
| 09 Mar 2007 | Oriental Bank Of Commerce | ₹5.00 M | Satisfied |
| 26 Jul 2006 | Oriental Bank Of Commerce | ₹2.95 Cr | Satisfied |
| 24 Jul 2006 | Oriental Bank Of Commerce | ₹2.50 Cr | Satisfied |
How Many Employees Work at Adietika Pharma?
Unlock and access historical data on people associated with Adietika Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Adietika Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Adietika Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
